Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01990209
Title Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications

estrogen-receptor positive breast cancer

breast cancer

progesterone-receptor positive breast cancer

triple-receptor negative breast cancer

Therapies

Orteronel

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale School of Medicine New Haven Connecticut 06520 United States Details
Northeast Georgia Medical Center Gainesville Georgia 30501 United States Details
Hope Cancer Center Terre Haute Indiana 47802 United States Details
Baptist Hospital East Louisville Kentucky 40207 United States Details
Center for Cancer and Blood Disorders Bethesda Maryland 20817 United States Details
Cancer Research Consortium of West Michigan Grand Rapids Michigan 49503 United States Details
Cancer Centers of SW Oklahoma Lawton Oklahoma 73505 United States Details
Tennessee Oncology PLLC Chattanooga Tennessee 37404 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
Center for Cancer and Blood Disorders Fort Worth Texas 76104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field